October 13, 2026 · 12 min read · Sugam Budhraja

FDA Cleared vs FDA Approved: What a Smart Ring's New Blood Pressure Clearance Actually Covers

A ring's blood pressure clearance made headlines as continuous and calibration-free. The FDA's own record says spot checks, ages 22 to 50, no diagnosis. How to read any wearable's health claim, with Apple, Samsung, WHOOP, Dexcom and Eversense as examples.

On 5 October, Happy Health announced what it called the first FDA clearance for cuffless, calibration-free blood pressure: a smart ring offering continuous, passive, clinical-grade tracking [1][2]. The FDA’s own record of that clearance, 510(k) K254000, tells a narrower story. It covers software for spot-check readings in adults aged 22 to 50, intended “only for measurement and display”, that “makes no diagnosis” and should not be used by people with atrial fibrillation or who are pregnant [3].

Both can be true at once. The clearance is real and genuinely new; the announcement describes where the company is heading, and the record describes what the FDA reviewed. The gap between the two is where most confusion about wearables lives, and the words used to describe it, approved, cleared, authorized, wellness and registered, are not interchangeable.

Key takeaways

  • Approved, cleared, authorized, wellness and registered are five different things. Only the first three involve an FDA review, and most wearable features are cleared or authorized, not approved.
  • Clearance is for a feature, a population and a use, not a device brand. Read the Indications for Use before you trust a headline.
  • A mean error is not accuracy. Ask for the spread of errors, the population and the reference method.
  • Wellness is not a verdict on quality. It means the FDA did not review it, in either direction.
  • Store regulatory status with the data. A cleared reading and a wellness estimate can have the same field name in Apple Health.

What did the FDA actually clear for the ring?

The announcement describes continuous, clinical-grade tracking; the FDA record covers spot checks in adults aged 22 to 50, with no diagnosis. Source: FDA 510(k) K254000.

The record is short and worth reading in full [3]:

  • What it is. Software as a medical device that analyzes PPG, electrodermal activity, accelerometer and skin temperature signals “from compatible, FDA cleared, hardware devices”. The ring is the hardware; the clearance is for the software.
  • What it produces. “Spot-check measurements of systolic and diastolic blood pressure in a home or clinical setting.” Spot checks, not a continuous stream.
  • Who it is for. “Subjects aged 22 to 50 years old.” Hypertension is far more common above 50, so most of the people who would benefit are outside the cleared population today.
  • What it does not do. It is “intended only for measurement and display; it makes no diagnosis.”
  • Who should not use it. People with arrhythmias such as atrial fibrillation, severe vascular disease, those on vasoactive drugs or who are pregnant, and nobody during motion or low perfusion.
  • How it was classified. Class II, regulation 21 CFR 870.1130, product code DXN, the same category as an ordinary non-invasive blood pressure monitor.

The company reports a mean error of 0.8 mmHg systolic and 0.1 mmHg diastolic against an arterial line, from 850 paired measurements in 85 patients [2]. That is a headline average. The next section explains why it is not, by itself, an accuracy figure.


What do approved, cleared, authorized, wellness and registered mean?

Only approved, authorized and cleared involve an FDA review; wellness and registered do not. Sources: FDA 510(k), De Novo and PMA databases.
LabelPathwayWhat the FDA looked atWearable example
ApprovedPremarket approval (PMA)Evidence that the device is safe and effective, usually clinical trialsEversense implantable CGM, approved 21 June 2018 [4]
Authorized or grantedDe NovoA new low to moderate risk device with no predicate; creates a new device typeApple’s ECG app (2018), Apple’s AirPods Pro Hearing Aid Feature (2024), Samsung’s sleep apnea feature (2024) [5][6][7]
Cleared510(k)Substantial equivalence to a device already on the marketApple’s Hypertension Notification Feature, K250507 (2025); Dexcom Stelo, the first over-the-counter CGM (2024); Happy Health blood pressure, K254000 (2026) [3][8][9]
General wellnessNoneNothing; the FDA does not actively regulate low-risk wellness productsSamsung’s US blood pressure feature; WHOOP’s Blood Pressure Insights after its 2025 warning letter [10][11][12]
Registered and listedNoneNothing; registration only tells the FDA a facility existsAny device whose only claim is “FDA registered” [13]

Three distinctions trip people up most:

  • Approved is rare for wearables. PMA is for higher-risk devices. Almost every consumer health feature on a watch, ring or phone is cleared or authorized, so “FDA approved” on a wearable is usually wrong.
  • Features are cleared, not watches. Apple’s ECG app and hypertension notification are FDA-reviewed features; the Apple Watch’s heart rate, sleep stages and VO2 max are not. The same device can carry cleared and uncleared numbers side by side.
  • “FDA registered” is not a review. The FDA says a registration and listing entry “does not denote approval, clearance, or authorization” of a facility or its devices, and that it issues no registration certificates [13]. A product leaning on registration is telling you something by what it leaves out.

A designation in the FDA’s Breakthrough Devices Program is also not a marketing authorization. It speeds review; it does not replace it [14].


How do you check a claim in five minutes?

  1. Find the number. Search the FDA’s 510(k), De Novo and PMA databases by company or device name [13]. Clearances start with K, De Novo grants with DEN, approvals with P. If you cannot find one, treat the product as unreviewed.
  2. Open the Indications for Use. It is usually one paragraph. Note what is measured, whether it is a number or a notification, spot check or continuous, home or clinic.
  3. Check the population. Age range, conditions excluded, prescription or over the counter. Happy Health’s is 22 to 50 [3]; Apple’s hypertension notification is for adults 22 and older without a prior diagnosis [8].
  4. Check whether it diagnoses. Many cleared features explicitly do not. Apple’s hypertension feature notifies; it does not diagnose or measure blood pressure [8].
  5. Compare with the marketing. Where the marketing promises more than the record, the record is what the FDA reviewed.

Why is a mean error not an accuracy figure?

Because errors in both directions cancel out. A device that reads 10 mmHg high for half its users and 10 mmHg low for the other half has a mean error of zero and is useless for any individual.

Blood pressure standards therefore require two numbers. Under the widely used ISO 81060-2 approach, the mean difference from the reference must be within 5 mmHg and the standard deviation of the differences within 8 mmHg, tested across a defined spread of people and pressures [15]. For any accuracy claim, ask:

  • What is the spread? The standard deviation or the share of readings within 5, 10 and 15 mmHg.
  • Against what reference? An arterial line is the most direct measurement but is used in hospital patients, who differ from people wearing a ring at home.
  • In whom? Age, skin tone, blood pressure range and conditions, compared with the cleared population.
  • Published where? A peer-reviewed study or the FDA summary, not a press release.

None of this is unique to Happy Health. Apple’s hypertension feature identified 41% of people with hypertension in its validation study, with 92% specificity, which is why it is a notification and not a measurement [8]. We worked through what that means per 1,000 people in cuffless blood pressure wearables.

Cleared is not the same as clinically accepted. The European Society of Hypertension and the American Heart Association have both said cuffless blood pressure devices do not yet have the evidence needed for clinical decisions such as diagnosis or changing medication, including devices that are cleared [16][17]. Clearance is a regulatory threshold; guidelines are a clinical one.

What about wellness features?

Under the FDA’s January 2026 general wellness guidance, low-risk products that support fitness, sleep or general health and make no disease claims are not actively regulated [10]. That is why the same measurement can be regulated in one product and not in another.

WHOOP is the clearest example. In July 2025 the FDA issued a warning letter saying Blood Pressure Insights was a medical device marketed without clearance [11]. In June 2026 the FDA closed the matter after WHOOP changed the feature and its labeling, and it now sits on the wellness side [12]. Samsung’s US blood pressure feature launched on 31 March 2026 as a wellness feature that requires cuff calibration every 28 days [18].

Wellness tells you the FDA did not review a product. It does not tell you the product is inaccurate, any more than clearance proves it is accurate for you. Our guide to the FDA’s January guidance covers how app makers end up on one side of the line or the other.


What should product teams do with this?

  • Store regulatory status as metadata. Apple Health and Health Connect use the same blood pressure fields for a cuff reading, a cleared ring reading and a wellness estimate. Keep the source, device and status alongside each value.
  • Do not borrow a feature’s clearance. If your app reads a cleared measurement and builds its own score on top, your score is not cleared.
  • Match your words to the record. “Measures”, “detects” and “diagnoses” are claims. Use the cleared language for cleared features and wellness language for everything else.
  • Respect the exclusions. If a feature is not cleared for pregnancy or atrial fibrillation, do not present it to users you know are pregnant or have atrial fibrillation as if it were.
  • Re-check after updates. Clearances are for specific software versions and uses. New populations or claims usually need a new submission.
Where Sahha sits. Sahha’s scores, biomarkers and insights are general wellness outputs and are not FDA cleared. Sahha keeps the source and device behind every value, so a product can tell a cleared measurement from an estimate and present each one correctly.

The short version

Approved means PMA, cleared means 510(k), authorized means De Novo, and wellness and registered mean the FDA did not review the product [4][13]. Most wearable health features are cleared or authorized, and the clearance is for a feature, a population and a use. Happy Health’s ring clearance is real and new, and it covers spot-check blood pressure in adults aged 22 to 50, with no diagnosis and clear exclusions [3]. Read the Indications for Use, ask for the spread of errors and not just the mean, and store regulatory status with the data.

References

  1. Fitt Insider. Happy Health’s Smart Ring Receives FDA Clearance for Cuffless Blood Pressure. 5 October 2026. https://insider.fitt.co/happy-healths-smart-ring-adds-blood-pressure-tracking/
  2. Sleep Review. FDA Clears Smart Ring for Cuffless, Calibrationless Blood Pressure Monitoring. 8 October 2026. https://sleepreviewmag.com/sleep-treatments/therapy-devices/emerging-technology/fda-clears-happy-ring-blood-pressure-monitoring/
  3. US Food and Drug Administration. 510(k) K254000, Happy Health Blood Pressure Monitor, Happy Health, Inc. Substantially equivalent, 3 September 2026. 21 CFR 870.1130, Class II, product code DXN. Indications for Use. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K254000
  4. US Food and Drug Administration. Premarket approval P160048, Eversense Continuous Glucose Monitoring System, Senseonics. Approved 21 June 2018. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?ID=P160048
  5. US Food and Drug Administration. De Novo DEN180044, ECG App, Apple Inc. September 2018. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?ID=DEN180044
  6. US Food and Drug Administration. FDA Authorizes First Over-the-Counter Hearing Aid Software. 12 September 2024. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-over-counter-hearing-aid-software
  7. US Food and Drug Administration. De Novo DEN230041, Samsung Sleep Apnea Feature. February 2024. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?ID=DEN230041
  8. US Food and Drug Administration. 510(k) K250507, Hypertension Notification Feature, Apple Inc. Cleared 11 September 2025. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K250507
  9. US Food and Drug Administration. FDA Clears First Over-the-Counter Continuous Glucose Monitor. 5 March 2024. https://www.fda.gov/news-events/press-announcements/fda-clears-first-over-counter-continuous-glucose-monitor
  10. US Food and Drug Administration. General Wellness: Policy for Low Risk Devices. Final guidance, 6 January 2026. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/general-wellness-policy-low-risk-devices
  11. US Food and Drug Administration. Warning Letter to WHOOP, Inc., 709755, 14 July 2025. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/whoop-inc-709755-07142025
  12. STAT. FDA drops enforcement against wearable maker Whoop. 23 June 2026. https://www.statnews.com/2026/06/23/fda-drops-enforcement-against-wearable-maker-whoop/
  13. US Food and Drug Administration. Are There “FDA Registered” or “FDA Certified” Medical Devices? How Do I Know What Is FDA Approved? https://www.fda.gov/medical-devices/consumers-medical-devices/are-there-fda-registered-or-fda-certified-medical-devices-how-do-i-know-what-fda-approved
  14. US Food and Drug Administration. Breakthrough Devices Program. https://www.fda.gov/medical-devices/how-study-and-market-your-device/breakthrough-devices-program
  15. Stergiou, G. S., Alpert, B., Mieke, S., et al. (2018). A universal standard for the validation of blood pressure measuring devices: AAMI/ESH/ISO Collaboration Statement. Hypertension, 71(3), 368 to 374. https://doi.org/10.1161/HYPERTENSIONAHA.117.10237
  16. Stergiou, G. S., Avolio, A. P., Palatini, P., et al. (2023). European Society of Hypertension recommendations for the validation of cuffless blood pressure measuring devices. Journal of Hypertension. https://doi.org/10.1097/HJH.0000000000003483
  17. Cohen, J. B., Byfield, R. L., Hardy, S. T., et al. (2025). Cuffless Devices for the Measurement of Blood Pressure: A Scientific Statement From the American Heart Association. Hypertension. https://doi.org/10.1161/HYP.0000000000000254
  18. Samsung Newsroom US. Samsung’s Blood Pressure Monitoring Feature Now Available to U.S. Users in Samsung Health. 31 March 2026. https://news.samsung.com/us/samsung-blood-pressure-monitoring-feature-available/

Related